Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Diabetic nephropathy: is ESRD its only heritable phenotype?

Pezzolesi MG, Krolewski AS.

J Am Soc Nephrol. 2013 Oct;24(10):1505-7. doi: 10.1681/ASN.2013070769. No abstract available.

2.

Chromosome 2q31.1 associates with ESRD in women with type 1 diabetes.

Sandholm N, McKnight AJ, Salem RM, Brennan EP, Forsblom C, Harjutsalo V, Mäkinen VP, McKay GJ, Sadlier DM, Williams WW, Martin F, Panduru NM, Tarnow L, Tuomilehto J, Tryggvason K, Zerbini G, Comeau ME, Langefeld CD; FIND Consortium., Godson C, Hirschhorn JN, Maxwell AP, Florez JC, Groop PH; FinnDiane Study Group and the GENIE Consortium..

J Am Soc Nephrol. 2013 Oct;24(10):1537-43. doi: 10.1681/ASN.2012111122.

3.

High-density single nucleotide polymorphism genome-wide linkage scan for susceptibility genes for diabetic nephropathy in type 1 diabetes: discordant sibpair approach.

Rogus JJ, Poznik GD, Pezzolesi MG, Smiles AM, Dunn J, Walker W, Wanic K, Moczulski D, Canani L, Araki S, Makita Y, Warram JH, Krolewski AS.

Diabetes. 2008 Sep;57(9):2519-26. doi: 10.2337/db07-1086.

4.

CD2AP is associated with end-stage renal disease in patients with type 1 diabetes.

Hyvönen ME, Ihalmo P, Sandholm N, Stavarachi M, Forsblom C, McKnight AJ, Lajer M, Maestroni A, Lewis G, Tarnow L, Maestroni S, Zerbini G, Parving HH, Maxwell AP, Groop PH, Lehtonen S.

Acta Diabetol. 2013 Dec;50(6):887-97. doi: 10.1007/s00592-013-0475-9.

PMID:
23681557
5.

Meta-analysis of the relationship between ACE I/D gene polymorphism and end-stage renal disease in patients with diabetic nephropathy.

Yu ZY, Chen LS, Zhang LC, Zhou TB.

Nephrology (Carlton). 2012 Jul;17(5):480-7. doi: 10.1111/j.1440-1797.2012.01592.x. Review.

PMID:
22385293
6.

A polymorphism in the gene encoding carnosinase (CNDP1) as a predictor of mortality and progression from nephropathy to end-stage renal disease in type 1 diabetes mellitus.

Alkhalaf A, Bakker SJ, Bilo HJ, Gans RO, Navis GJ, Postmus D, Forsblom C, Groop PH, Vionnet N, Hadjadj S, Marre M, Parving HH, Rossing P, Tarnow L.

Diabetologia. 2010 Dec;53(12):2562-8. doi: 10.1007/s00125-010-1863-0.

7.

Methylenetetrahydrofolate reductase gene polymorphism and susceptibility to diabetic nephropathy in type 1 diabetes.

Makita Y, Moczulski DK, Bochenski J, Smiles AM, Warram JH, Krolewski AS.

Am J Kidney Dis. 2003 Jun;41(6):1189-94.

PMID:
12776270
8.

The diabetic patient with renal failure.

Ritz E, Schömig M.

Nefrologia. 2000;20 Suppl 3:16-24. Review. No abstract available.

9.

Polymorphism of catalase gene promoter in Romanian patients with diabetic kidney disease and type 1 diabetes.

Panduru NM, Moţa E, Moţa M, Cimponeriu D, Serafinceanu C, Cheţa DM.

Rom J Intern Med. 2010;48(1):81-8.

PMID:
21180245
10.

Replication study for the association of 3 SNP loci identified in a genome-wide association study for diabetic nephropathy in European type 1 diabetes with diabetic nephropathy in Japanese patients with type 2 diabetes.

Maeda S, Imamura M, Kurashige M, Araki S, Suzuki D, Babazono T, Uzu T, Umezono T, Toyoda M, Kawai K, Imanishi M, Hanaoka K, Maegawa H, Uchigata Y, Hosoya T.

Clin Exp Nephrol. 2013 Dec;17(6):866-71. doi: 10.1007/s10157-013-0797-5.

PMID:
23543049
11.

Investigation of the association of BMP gene variants with nephropathy in Type 1 diabetes mellitus.

McKnight AJ, Pettigrew KA, Patterson CC, Kilner J, Sadlier DM, Maxwell AP; Warren 3/UK GoKinD Study Group..

Diabet Med. 2010 Jun;27(6):624-30. doi: 10.1111/j.1464-5491.2010.02976.x.

PMID:
20546278
12.

Genetic variation in the Renin-Angiotensin system and progression of diabetic nephropathy.

Jacobsen P, Tarnow L, Carstensen B, Hovind P, Poirier O, Parving HH.

J Am Soc Nephrol. 2003 Nov;14(11):2843-50.

13.

Effects of MCF2L2, ADIPOQ and SOX2 genetic polymorphisms on the development of nephropathy in type 1 Diabetes Mellitus.

Zhang D, Efendic S, Brismar K, Gu HF.

BMC Med Genet. 2010 Jul 28;11:116. doi: 10.1186/1471-2350-11-116.

14.

Elevated MBL concentrations are not an indication of association between the MBL2 gene and type 1 diabetes or diabetic nephropathy.

Kaunisto MA, Sjölind L, Sallinen R, Pettersson-Fernholm K, Saraheimo M, Fröjdö S, Forsblom C, Fagerudd J, Hansen TK, Flyvbjerg A, Wessman M, Groop PH; FinnDiane Study Group..

Diabetes. 2009 Jul;58(7):1710-4. doi: 10.2337/db08-1495.

15.

SOX2 has gender-specific genetic effects on diabetic nephropathy in samples from patients with type 1 diabetes mellitus in the GoKinD study.

Gu HF, Alvarsson A, Efendic S, Brismar K.

Gend Med. 2009 Dec;6(4):555-64. doi: 10.1016/j.genm.2009.11.001.

PMID:
20114006
16.

A family-based strategy to identify genes for diabetic nephropathy.

Covic AM, Iyengar SK, Olson JM, Sehgal AR, Constantiner M, Jedrey C, Kara M, Sabbagh E, Sedor JR, Schelling JR.

Am J Kidney Dis. 2001 Mar;37(3):638-47.

PMID:
11228193
17.

Evidence for different susceptibility genes for proteinuria and ESRD in type 2 diabetes.

Placha G, Canani LH, Warram JH, Krolewski AS.

Adv Chronic Kidney Dis. 2005 Apr;12(2):155-69. Review.

PMID:
15822051
18.

Impact of nitric oxide synthase Glu298Asp polymorphism on the development of end-stage renal disease in type 2 diabetic Egyptian patients.

El-Din Bessa SS, Hamdy SM.

Ren Fail. 2011;33(9):878-84. doi: 10.3109/0886022X.2011.605978.

PMID:
21854353
19.

SLC12A3 (solute carrier family 12 member [sodium/chloride] 3) polymorphisms are associated with end-stage renal disease in diabetic nephropathy.

Kim JH, Shin HD, Park BL, Moon MK, Cho YM, Hwang YH, Oh KW, Kim SY, Lee HK, Ahn C, Park KS.

Diabetes. 2006 Mar;55(3):843-8.

20.

Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus.

Freedman BI, Tuttle AB, Spray BJ.

Am J Kidney Dis. 1995 May;25(5):710-3.

PMID:
7747724
Items per page

Supplemental Content

Support Center